Ro Announces Agreement With NIH National Institute on Aging


Ro announced an agreement with the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to create the "Registry for Equal Access to Clinical Trials in Alzheimer’s Disease (AD)" (REACT-AD). As part of the agreement, Ro will use its telehealth platform to screen and recruit patients who may be at an elevated risk for AD or a related dementia to join a registry of potential participants in NIA-conducted and funded clinical trials.

Read more about the agreement here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.